- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chorea associated with Huntington's disease
- Meeting Date: March 2021
- Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 1.4MB)
- Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 153KB)
Deutetrabenazine – March 2021
Deutetrabenazine: Tablet 6 mg, Tablet 9 mg, Tablet 12 mg; Austedo®
Last updated
16 July 2021